Specific targeting of cancer cells by multifunctional mitoxantrone- conjugated magnetic nanoparticles

Journal of Drug Targeting

Volumn 21, Issue 4, 2013, Pages 328-340

  Heidari Majd, Mostafa ^a,b   Asgari, Davoud ^a,b   Barar, Jaleh ^a,b,c   Valizadeh, Hadi ^a,b   Kafil, Vala ^a,b   Coukos, George ^c   Omidi, Yadollah ^a,b,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer; Cancer targeting; Drug delivery; Drug targeting; Folate; Mitoxantrone; Nanomedicine; Theranostics

Indexed keywords

AMINO ACID DERIVATIVE; DOPAMINE; DOPAMINE POLYETHYLENE GLYCOL FOLIC ACID; ETHYLENEDIAMINE; FERRIC OXIDE; FERRIC OXIDE NANOPARTICLE; FOLATE RECEPTOR; FOLIC ACID; FOLIC ACID DERIVATIVE; MACROGOL; MACROGOL DERIVATIVE; MAGNETIC NANOPARTICLE; METAL NANOPARTICLE; MITOXANTRONE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; CROSS COUPLING REACTION; CYTOTOXICITY; DECOMPOSITION; DRUG BINDING; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SYNTHESIS; DRUG TARGETING; ELECTRON MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; NANOENGINEERING; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; THERMAL DECOMPOSITION REACTION;

EID: 84877136120     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2012.750325     Document Type: Article

References (54)

1. Robinson I, Tung LD, Maenosono S, et al. Synthesis of core-shell gold coated magnetic nanoparticles and their interaction with thiolated DNA. Nanoscale 2010;2:2624-30.
2. Zhou J, Wu W, Caruntu D, et al. Synthesis of porous magnetic hollow silica nanospheres for nanomedicine application. J Phys Chem C 2007;111:17473-7.
3. 3: preparation and potential application in drug delivery. J Phys Chem C 2008;112:1851-6.
4. Mittal VV, Patel SJ, Sheth SK. Development and characterization of folate targeted nanoparticle drug delivery system. Int J Pharma BioSci 2010;1:1-12.
5. Prijic S, Sersa G. Magnetic nanoparticles as targeted delivery systems in oncology. Radiol Oncol 2011;45:1-16.
6. Kohler N, Sun C, Wang J, Zhang M. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir 2005;21:8858-64.
7. Kohler N, Fryxell GE, Zhang M. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc 2004;126:7206-11.
8. Shubayev VI, Pisanic 2nd TR, Jin S. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 2009;61:467-77.
9. Aronov O, Horowitz AT, Gabizon A, Gibson D. Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies. Bioconjugate Chem 2003;14:563-74.
10. Gautier J, Munnier E, Paillard A, et al. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting. Int J Pharm 2012;423:16-25.
11. Low PS, Kularatne SA. Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol 2009;13:256-62.
12. Xia W, Low PS. Folate-targeted therapies for cancer. J Med Chem 2010;53:6811-24.
13. Hu FX, Neoh KG, Kang ET. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nano-particles. Biomaterials 2006;27:5725-33.
14. Yoo HS, Park TG. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Release 2004;100:247-56.
15. Kim SY, Lee YM. Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers. Biomaterials 2001;22:1697-704.
16. Jain TK, Richey J, Strand M, et al. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 2008;29:4012-21.
17. Arias JL, Gallardo V, Ruiz MA, Delgado AV. Magnetite/ polyalkylcyanoacrylate) core/shell) nanoparticles as 5-fluorouracil delivery systems for active targeting. Eur J Pharm Biopharm 2008;69:54-63.
18. Zhang J, Rana S, Srivastava RS, Misra RD. On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles. Acta Biomater 2008;4:40-8.
19. Tietze R, Schreiber E, Lyer S, Alexiou C. Mitoxantrone loaded superparamagnetic nanoparticles for drug targeting: a versatile and sensitive method for quantification of drug enrichment in rabbit tissues using HPLC-UV. J Biomed Biotechnol 2010;2010 (Article ID 597304):8pp.
20. Alexiou C, Jurgons R, Schmid RJ, et al. Magnetic drug targeting biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target 2003;11:139-49.
21. Krukemeyer MG, Krenn V, Jakobs M, Wagner W. Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetite-dextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets-sarcoma treatment in progress. J Drug Target 2012;20:185-93.
22. Moros M, Pelaz B, Lopez-Larrubia P, et al. Engineering biofunctional magnetic nanoparticles for biotechnological applications. Nanoscale 2010;2:1746-55.
23. 4 nanoparticles. J Am Chem Soc 2008;130: 14436-7.
24. Sonvico F, Mornet S, Vasseur S, et al. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjugate Chem 2005;16:1181-8.
25. Li M, Selvin PR. Amine-reactive forms of a luminescent diethylenetriaminepentaacetic acid chelate of terbium and europium: attachment to DNA and energy transfer measurements. Bioconjugate Chem 1997;8:127-2.
26. Hou Y, Xu Z, Sun S. Controlled synthesis and chemical conversions of FeO nanoparticles. Angew Chem 2007;119:6445-8.
27. Kafil V, Omidi Y. Cytotoxic impacts of linear and branched polyethylenimine nanostructures in A431 cells. BioImpacts 2011;1:23-30.
28. Omidi Y, Barar J. Induction of human alveolar epithelial cell growth factor receptors by dendrimeric nanostructures. Int J Toxicol 2009;28:113-22.
29. Leoz MLAD, Chua MT, Endoma-Arias MAA, et al. A modified procedure for the preparation of mitoxantrone. Philippine J Sci 2006;135:83-92.
30. Nakhlband A, Barar J, Bidmeshkipour A, et al. Bioimpacts of anti epidermal growth factor receptor antisense complexed with polyamidoamine dendrimers in human lung epithelial adenocarci-noma cells. J Biomed Nanotech 2010;6:360-9.
31. Omidi Y, Hollins AJ, Benboubetra M, et al. Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin-and oligofectamine-induced gene expression changes in human epithelial cells. J Drug Target 2003;11:311-23.
32. Bae KH, Kim YB, Lee Y, et al. Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast T1-and T2-weighted magnetic resonance imaging. Bioconjugate Chem 2010;21:505-12.
33. Kumagai M, Sarma TK, Cabral H, et al. Enhanced in vivo magnetic resonance imaging of tumors by pegylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties. Macromol Rapid Commun 2010;31:1521-8.
34. Larsen EK, Nielsen T, Wittenborn T, et al. Size-dependent accumulation of PEGylated silane-coated magnetic iron oxide nanoparticles in murine tumors. ACS Nano 2009;3:1947-51.
35. Wu SH, Lin CY, Hung Y, et al. PEGylated silica nanoparticles encapsulating multiple magnetite nanocrystals for high-performance microscopic magnetic resonance angiography. J Biomed Mater Res B Appl Biomater 2011;99:81-8.
36. 4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv Mater 2007;19:3163-6.
37. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005;26:3995-4021.
38. Zhang Y, Kohler N, Zhang M. Surface modification of super-paramagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002;23:1553-61.
39. Kang SM, Choi IS, Lee KB, Kim Y. Bioconjugation of poly(poly(ethylene glycol) methacrylate)-coated iron oxide magnetic nanoparticles for magnetic capture of target proteins. Macromol Res 2009;17:259-64.
40. Lenk H, Muller U, Tanneberger S. Mitoxantrone: mechanism of action, antitumor activity, pharmacokinetics, efficacy in the treatment of solid tumors and lymphomas, and toxicity. Anticancer Res 1987;7:1257-64.
41. Zagotto G, Sissi C, Gatto B, Palumbo M. Aminoacyl-analogues of mitoxantrone as novel DNA-damaging cytotoxic agents. Arkivoc 2004;V:204-18.
42. Fox EJ. Management of worsening multiple sclerosis with mitoxantrone: a review. Clin Ther 2006;28:461-74.
43. Li K, Jiang Y, Ding D, et al. Folic acid-functionalized two-photon absorbing nanoparticles for targeted MCF-7 cancer cell imaging. Chem Commun 2011;47:7323-5.
44. Lu JY, Lowe DA, Kennedy MD, Low PS. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug. J Drug Target 1999;7:43-53.
45. Xu Z, Shen C, Hou Y, et al. Oleylamine as both reducing agent and stabilizer in a facile synthesis of magnetite nanoparticles. Chem Mater 2009;21:1778-80.
46. Afrimzon E, Deutsch A, Shafran Y, et al. Intracellular esterase activity in living cells may distinguish between metastatic and tumor-free lymph nodes. Clin Exp Metastasis 2008;25:213-24.
47. Kallunki T, Olsen OD, Jaattela M. Cancer-associated lysosomal changes: friends or foes? Oncogene 2012;2012:209.
48. Yang H, Lou C, Xu M, et al. Investigation of folate-conjugated fluorescent silica nanoparticles for targeting delivery to folate receptor-positive tumors and their internalization mechanism. Int J Nanomed 2011;6:2023-32.
49. Rothberg KG, Ying YS, Kolhouse JF, et al. The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway. J Cell Biol 1990;110: 637-49.
50. Rijnboutt S, Jansen G, Posthuma G, et al. Endocytosis of GPI-linked membrane folate receptor-alpha. J Cell Biol 1996;132: 35-47.
51. Kim CH, Park YS, Chung KN, Elwood PC. Sorting and function of the human folate receptor is independent of the caveolin expression in Fisher rat thyroid epithelial cells. J Biochem Mol Biol 2002;35:395-402.
52. Adolphi NL, Butler KS, Lovato DM, et al. Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI. Contrast Media Mol Imaging 2012;7:308-19.
53. Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG. Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Expert Rev Clin Pharmacol 2012;5:173-86.
54. Krukemeyer MG, Krenn V, Jakobs M, Wagner W. Mitoxantrone-iron oxide biodistribution in blood, tumor, spleen, and liver-magnetic nanoparticles in cancer treatment. J Surg Res 2012;175: 35-43.